Cataract
Conditions
Keywords
Best-corrected visual acuity, posterior capsule opacification, QUATRIX® Aspheric Evolutive pre-loaded
Brief summary
To describe biocompatibility, postoperative results and complications after implantation of the Corneal Quatrix Evolutive (Corneal, Croma, Austria) intraocular lens, a hydrophilic acrylic intraocular lens (IOL) with 4-haptic design and 360° sharp optic edge.
Detailed description
In this prospective case series the Corneal Quatrix Evolutive IOL was implanted in 14 eyes of nine patients with senile cortico-nuclear cataract. A standardized surgical technique and post-operative regimen were applied. Six months postoperatively best corrected visual acuity (BCVA), refraction and complications (especially) posterior capsule opacification (PCO) were analysed.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
Patients with senile cortico-nuclear cataracts without previous intraocular surgery
Exclusion criteria
* Dilated pupil size of \< 6 mm * long-term anti-inflammatory treatment * previous history of intraocular surgery * previous history of corneal endothelial damage * previous history of ocular trauma * traumatic cataract * history of uveitis * diabetic retinopathy * advanced macular degeneration
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Best-corrected visual acuity (BCVA) | Six months | The best-corrected visual acuity is assessed with glasses after cataract operation |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Posterior capsule opacification | Six months | The posterior capsule opacification is assessed by slit lamp examination and subjective grading |
Countries
Austria